Atomoxetine
NDC Package 65841-607-77

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Atomoxetine is a . Marketed by Zydus Lifesciences Limited, this product is identified by NDC 65841-607 and is authorized under FDA application ANDA079017.

Identification & Billing

NDC Package Code
65841-607-77
Package Description
10 BLISTER PACK in 1 CARTON / 10 CAPSULE in 1 BLISTER PACK (65841-607-30)
Product Code
11-Digit Billing Format
65841060777

Clinical Specifications

Proprietary Name
Atomoxetine
Dosage Form
-

Regulatory & Marketing

Labeler Name
Zydus Lifesciences Limited
FDA Application #
ANDA079017
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-06-2017
End Marketing Date
03-21-2025
Listing Expiration
03-21-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (65841-607). Click a package code to view its specific billing and regulatory data.

2000 CAPSULE in 1 BOTTLE
30 CAPSULE in 1 BOTTLE
1000 CAPSULE in 1 BOTTLE
60 CAPSULE in 1 BOTTLE
90 CAPSULE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 65841-607-77 identifies a specific commercial package of 10 blister pack in 1 carton / 10 capsule in 1 blister pack (65841-607-30) of Atomoxetine, labeled by Zydus Lifesciences Limited. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Zydus Lifesciences Limited on December 06, 2017. The current certification is valid through March 21, 2025.

How is this Zydus Lifesciences Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 65841060777. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
65841-607-77
11-Digit CMS (5-4-2)
65841-0607-77

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.